{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:27:16Z","timestamp":1793698036695,"version":"4.5.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The University of Sydney","id":[{"id":"https:\/\/ror.org\/0384j8v12","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Medication-related readmissions are a significant and preventable cause of patient harm. Patients living in rural and remote areas may face inequitable access to healthcare and fragmented continuity of care, increasing their vulnerability to medication-related harm. Despite this, the burden and drivers of medication-related readmissions in these settings remain poorly understood. Determining the current burden and identifying factors associated with medication-related readmissions is essential to inform targeted strategies to improve medication safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To determine the proportion of adult patients with a medication-related readmission within 30\u00a0days of discharge from rural and remote hospitals, and to identify factors potentially associated with these readmissions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted using medical records of adults admitted to rural and remote hospitals in New South Wales, Australia, between June 1, 2022 and August 31, 2023. Readmissions within 30\u00a0days were assessed for medication-related causes using the AT-HARM10, a validated 10-item tool based on admission notes, medication lists, inpatient pathology results, and discharge summaries. Patient demographics, comorbidities and admission details were extracted. Comorbidity burden was calculated using the Charlson Comorbidity Index (CCI). Medication lists were based on medications charted 12\u00a0h before discharge. Univariable logistic regression was performed to explore factors associated with 30-day medication-related readmissions, with results reported as unadjusted odds ratios (uOR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 2220 patients admitted during the study period, 6% (n\u2009=\u2009133) experienced a 30-day readmission, of which 22.5% (n\u2009=\u200930) were medication-related. Overall, 1.4% of all admitted patients experienced a 30-day medication-related readmission. Older age (uOR 1.04; 95% CI 1.01\u20131.07), higher CCI (uOR 1.22; 95% CI 1.04\u20131.44), a greater number of regular medications (uOR 1.07 per additional medication; 95% CI 1.01\u20131.14), and insulin use (uOR 2.80; 95% CI 1.06\u20137.42) were associated with medication-related readmission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In rural and remote hospitals, a small but clinically important proportion of patients experienced a medication-related readmission within 30\u00a0days of discharge. Unadjusted analysis identified that older age, multimorbidity, polypharmacy and insulin use were associated with increased risk. Larger studies are needed to validate these findings and evaluate strategies to reduce medication-related harm in rural and remote populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-026-02228-7","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:33:37Z","timestamp":1791362017000},"page":"2504-2512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proportion of patients admitted to rural and remote hospitals that experience a 30-day medication-related readmission: a retrospective cohort study"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1813-9620","authenticated-orcid":false,"given":"Kingston","family":"Yeung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5017-2869","authenticated-orcid":false,"given":"Gi Kon","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Englezos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9322-4102","authenticated-orcid":false,"given":"Aagam","family":"Bordia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4670-0884","authenticated-orcid":false,"given":"Stephen","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4043-6728","authenticated-orcid":false,"given":"Rebekah","family":"Moles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0248-7241","authenticated-orcid":false,"given":"Hana","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6735-9876","authenticated-orcid":false,"given":"Manya","family":"Angley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1910-5561","authenticated-orcid":false,"given":"Charley","family":"Budgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5717-6099","authenticated-orcid":false,"given":"Brett","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5920-8702","authenticated-orcid":false,"given":"Jenny","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9455-1898","authenticated-orcid":false,"given":"Deirdre","family":"Criddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7750-9724","authenticated-orcid":false,"given":"Rohan A.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5053-4591","authenticated-orcid":false,"given":"Tara","family":"Emadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3870-0822","authenticated-orcid":false,"given":"Cristen","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9301-0437","authenticated-orcid":false,"given":"Deborah","family":"Hawthorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5831-7358","authenticated-orcid":false,"given":"Linda","family":"Krogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0372-4373","authenticated-orcid":false,"given":"Anna","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2726-9109","authenticated-orcid":false,"given":"Simon","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3639-0787","authenticated-orcid":false,"given":"Frank M.","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9317-0145","authenticated-orcid":false,"given":"Paul","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1048-9116","authenticated-orcid":false,"given":"Jerry","family":"Yik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9606-7135","authenticated-orcid":false,"given":"Jonathan","family":"Penm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"4","key":"2228_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/BF02600255","volume":"10","author":"DW Bates","year":"1995","unstructured":"Bates DW, Boyle DL, Vliet MBV, et al. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10(4):199\u2013205. https:\/\/doi.org\/10.1007\/BF02600255.","journal-title":"J Gen Intern Med"},{"key":"2228_CR2","unstructured":"Panagioti M, Hodkinson A, Planner C et al. Global burden of preventable medication-related harm in health care : a systematic review. World Health Organization, Geneva. 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240088887. Accessed 15 Jun 2026."},{"issue":"5","key":"2228_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/pds.4188","volume":"26","author":"EK Walsh","year":"2017","unstructured":"Walsh EK, Hansen CR, Sahm LJ, et al. Economic impact of medication error: a systematic review. Pharmacoepidemiol Drug Saf. 2017;26(5):481\u201397. https:\/\/doi.org\/10.1002\/pds.4188.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2228_CR4","unstructured":"Medication Safety in Transitions of Care. In: Medication without harm Global Patient Safety Challenge. World Health Organization,. 2019. https:\/\/www.who.int\/publications\/i\/item\/WHO-UHC-SDS-2019.9. Accessed 15 Jun 2026."},{"key":"2228_CR5","unstructured":"Medication without harm WHO Global Patient safety Challenge Australia\u2019s response. Australian Commission on Safety and Quality in Health Care,. 2020. https:\/\/www.safetyandquality.gov.au\/resources\/medication-without-harm-who-global-patient-safety-challenge-australias-response. Accessed 15 Jun 2026."},{"issue":"3","key":"2228_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40264-021-01144-1","volume":"45","author":"R Lim","year":"2022","unstructured":"Lim R, Ellett LMK, Semple S, et al. The extent of medication-related hospital admissions in Australia: a review from 1988 to 2021. Drug Saf. 2022;45(3):249\u201357. https:\/\/doi.org\/10.1007\/s40264-021-01144-1.","journal-title":"Drug Saf"},{"issue":"3","key":"2228_CR7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/jgs.15244","volume":"66","author":"N El Morabet","year":"2018","unstructured":"El Morabet N, Uitvlugt EB, van den Bemt BJF, et al. Prevalence and preventability of drug-related hospital readmissions: a systematic review. J Am Geriatr Soc. 2018;66(3):602\u20138. https:\/\/doi.org\/10.1111\/jgs.15244.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"2228_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s40264-020-00918-3","volume":"43","author":"FA Alqenae","year":"2020","unstructured":"Alqenae FA, Steinke D, Keers RN. Prevalence and nature of medication errors and medication-related harm following discharge from hospital to community settings: a systematic review. Drug Saf. 2020;43(6):517\u201337. https:\/\/doi.org\/10.1007\/s40264-020-00918-3.","journal-title":"Drug Saf"},{"issue":"6","key":"2228_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.amjopharm.2011.10.005","volume":"9","author":"R Desai","year":"2011","unstructured":"Desai R, Williams CE, Greene SB, et al. Medication errors during patient transitions into nursing homes: characteristics and association with patient harm. Am J Geriatr Pharmacother. 2011;9(6):413\u201322. https:\/\/doi.org\/10.1016\/j.amjopharm.2011.10.005.","journal-title":"Am J Geriatr Pharmacother"},{"key":"2228_CR10","unstructured":"Emadi F, Liu S, Yiu CH et al. Strategies to facilitate safer medication management at transitions of care. In: Evidence briefings on interventions supporting safer transitions of care. Australians Commission on Safety and Quality in Health Care. 2024. https:\/\/www.safetyandquality.gov.au\/resources\/evidence-briefing-strategies-facilitate-safer-medication-management-transitions-care. Accessed 15 Jun 2026."},{"issue":"2","key":"2228_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1440-1584.2008.00953.x","volume":"16","author":"KB Smith","year":"2008","unstructured":"Smith KB, Humphreys JS, Wilson MGA. Addressing the health disadvantage of rural populations: how does epidemiological evidence inform rural health policies and research? Aust J Rural Health. 2008;16(2):56\u201366. https:\/\/doi.org\/10.1111\/j.1440-1584.2008.00953.x.","journal-title":"Aust J Rural Health"},{"issue":"3","key":"2228_CR12","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/ajr.13121","volume":"32","author":"CH Cortie","year":"2024","unstructured":"Cortie CH, Garne D, Parker-Newlyn L, et al. The Australian health workforce: disproportionate shortfalls in small rural towns. Aust J Rural Health. 2024;32(3):538\u201346. https:\/\/doi.org\/10.1111\/ajr.13121.","journal-title":"Aust J Rural Health"},{"issue":"5","key":"2228_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5694\/mja2.50041","volume":"210","author":"J Wakerman","year":"2019","unstructured":"Wakerman J, Humphreys JS. \u201cBetter health in the bush\u201d: why we urgently need a national rural and remote health strategy. Med J Aust. 2019;210(5):202\u20133. https:\/\/doi.org\/10.5694\/mja2.50041.","journal-title":"Med J Aust"},{"key":"2228_CR14","unstructured":"WHO guideline on health workforce development, attraction, recruitment and retention in rural and remote areas. World Health Organization. 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240024229. Accessed 15 Jun 2026."},{"issue":"6","key":"2228_CR15","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.japh.2017.06.019","volume":"57","author":"KL Pellegrin","year":"2017","unstructured":"Pellegrin KL, Lee E, Uyeno R, et al. Potentially preventable medication-related hospitalizations: a clinical pharmacist approach to assessment, categorization, and quality improvement. J Am Pharm Assoc. 2017;57(6):711\u20136. https:\/\/doi.org\/10.1016\/j.japh.2017.06.019.","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"2228_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1186\/s12913-023-10028-2","volume":"23","author":"N Sch\u00f6nenberger","year":"2023","unstructured":"Sch\u00f6nenberger N, Meyer-Massetti C. Risk factors for medication-related short-term readmissions in adults\u2014a scoping review. BMC Health Serv Res. 2023;23(1):1037. https:\/\/doi.org\/10.1186\/s12913-023-10028-2.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"2228_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"key":"2228_CR18","unstructured":"Strategic Plan 2020\u20132025. Western NSW Local Health District,. 2020. https:\/\/www.nsw.gov.au\/departments-and-agencies\/wnswlhd\/about-us\/western-nsw-lhd-strategies-plans-and-reports\/wnswlhd-strategic-plan. Accessed 16 Jun 2026."},{"key":"2228_CR19","unstructured":"Modified Monash Model. Australian Government Department of Health Disability and Ageing, . 2025. https:\/\/www.health.gov.au\/topics\/rural-health-workforce\/classifications\/mmm?language=und#what-is-the-mmm-used-for. Accessed 16 Jun 2026."},{"issue":"1","key":"2228_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11096-018-0768-8","volume":"41","author":"TGH Kempen","year":"2019","unstructured":"Kempen TGH, Hedstr\u00f6m M, Olsson H, et al. Assessment tool for hospital admissions related to medications: development and validation in older patients. Int J Clin Pharm. 2019;41(1):198\u2013206. https:\/\/doi.org\/10.1007\/s11096-018-0768-8.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"2228_CR21","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1007\/s11096-022-01456-x","volume":"44","author":"TGH Kempen","year":"2022","unstructured":"Kempen TGH, Hedman A, Gillespie U. Drug-related emergency department visits in older patients: an applicability and reliability study of an existing assessment tool. Int J Clin Pharm. 2022;44(4):1078\u201382. https:\/\/doi.org\/10.1007\/s11096-022-01456-x.","journal-title":"Int J Clin Pharm"},{"issue":"7","key":"2228_CR22","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1016\/j.sapharm.2021.08.014","volume":"18","author":"DT Criddle","year":"2022","unstructured":"Criddle DT, Devine B, Murray K, et al. Developing PHarmacie-R: a bedside risk prediction tool with a medicines management focus to identify risk of hospital readmission. Res Social Adm Pharm. 2022;18(7):3137\u201348. https:\/\/doi.org\/10.1016\/j.sapharm.2021.08.014.","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"2228_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"issue":"1","key":"2228_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40266-023-01076-8","volume":"41","author":"N Prasad","year":"2024","unstructured":"Prasad N, Lau ECY, Wojt I, et al. Prevalence of and risk factors for drug-related readmissions in older adults: a systematic review and meta-analysis. Drugs Aging. 2024;41(1):1\u201311. https:\/\/doi.org\/10.1007\/s40266-023-01076-8.","journal-title":"Drugs Aging"},{"issue":"5","key":"2228_CR25","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1111\/bcp.15621","volume":"89","author":"TGH Kempen","year":"2023","unstructured":"Kempen TGH, Hedman AN, Hadziosmanovic N, et al. Risk factors for and preventability of drug-related hospital revisits in older patients: a post-hoc analysis of a randomized clinical trial. Br J Clin Pharmacol. 2023;89(5):1575\u201387. https:\/\/doi.org\/10.1111\/bcp.15621.","journal-title":"Br J Clin Pharmacol"},{"key":"2228_CR26","unstructured":"Chronic Conditions. Australian Institute of Health and Welfare,. 2024. https:\/\/www.aihw.gov.au\/reports\/australias-health\/chronic-conditions. Accessed 16 Jun 2026."},{"key":"2228_CR27","unstructured":"APINCHS classification of high risk medicines. Australian Commission on Safety and Quality in Health Care,. https:\/\/www.safetyandquality.gov.au\/our-work\/medicines-safety-and-quality\/high-risk-medicines\/apinchs-classification-high-risk-medicines. Accessed 16 Jun 2026."},{"key":"2228_CR28","unstructured":"ATC Classification index with DDDs. WHO Collaborating Centre for Drug Statistics Methodology,, Oslo, Norway. 2024. https:\/\/atcddd.fhi.no\/atc_ddd_index\/. Accessed 16 Jun 2026."},{"issue":"6","key":"2228_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0002-9343(05)80053-1","volume":"90","author":"SE Frankl","year":"1991","unstructured":"Frankl SE, Breeling JL, Goldman L. Preventability of emergent hospital readmission. Am J Med. 1991;90(6):667\u201374. https:\/\/doi.org\/10.1016\/S0002-9343(05)80053-1.","journal-title":"Am J Med"},{"issue":"2","key":"2228_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jppr200030247","volume":"30","author":"DA Stowasser","year":"2000","unstructured":"Stowasser DA, Staatz CE, Stowasser M, et al. Identifying drug-related readmissions is there a better way of assessing the contribution of adverse medication events? Aust J Hosp Pharm. 2000;30(2):47\u201353. https:\/\/doi.org\/10.1002\/jppr200030247.","journal-title":"Aust J Hosp Pharm"},{"issue":"2","key":"2228_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bcp.12293","volume":"78","author":"A Al Hamid","year":"2014","unstructured":"Al Hamid A, Ghaleb M, Aljadhey H, et al. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol. 2014;78(2):202\u201317. https:\/\/doi.org\/10.1111\/bcp.12293.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2228_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson ME, Carrozzino D, Guidi J, et al. Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91(1):8\u201335. https:\/\/doi.org\/10.1159\/000521288.","journal-title":"Psychother Psychosom"},{"key":"2228_CR33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.biopha.2018.07.157","volume":"107","author":"B Giri","year":"2018","unstructured":"Giri B, Dey S, Das T, et al. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity. Biomed Pharmacother. 2018;107:306\u201328. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.157.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2228_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ecl.2012.03.001","volume":"41","author":"AL McCall","year":"2012","unstructured":"McCall AL. Insulin therapy and hypoglycemia. Endocrinol Metab Clin North Am. 2012;41(1):57\u201387. https:\/\/doi.org\/10.1016\/j.ecl.2012.03.001.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2228_CR35","doi-asserted-by":"publisher","first-page":"567424","DOI":"10.3389\/fphar.2021.567424","volume":"12","author":"EB Uitvlugt","year":"2021","unstructured":"Uitvlugt EB, Janssen MJA, Siegert CEH, et al. Medication-related hospital readmissions within 30 days of discharge: prevalence, preventability, type of medication errors and risk factors. Front Pharmacol. 2021;12:567424. https:\/\/doi.org\/10.3389\/fphar.2021.567424.","journal-title":"Front Pharmacol"},{"issue":"4","key":"2228_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/j.2055-2335.2011.tb00106.x","volume":"41","author":"M Rothwell","year":"2011","unstructured":"Rothwell M, Jukka C, Lum E, et al. Retrospective analysis of emergency readmissions to rural and regional hospitals. J Pharm Pract Res. 2011;41(4):290\u20134. https:\/\/doi.org\/10.1002\/j.2055-2335.2011.tb00106.x.","journal-title":"J Pharm Pract Res"},{"issue":"4","key":"2228_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1071\/PY20110","volume":"27","author":"B Rasmussen","year":"2021","unstructured":"Rasmussen B, Wynter K, Rawson HA, et al. Self-management of diabetes and associated comorbidities in rural and remote communities: a scoping review. Aust J Prim Health. 2021;27(4):243\u201354. https:\/\/doi.org\/10.1071\/PY20110.","journal-title":"Aust J Prim Health"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02228-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02228-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02228-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:39:41Z","timestamp":1793695181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02228-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2228"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02228-7","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All research materials and protocols were approved by the Western New South Wales Local Health District Ethics Committee (HREC: 2023\/ETH01292).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}